These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

421 related items for PubMed ID: 33099879

  • 1. Acute myeloid leukemia with mutated NPM1 mimics acute promyelocytic leukemia presentation.
    Arana Rosainz MJ, Nguyen N, Wahed A, Lelenwa LC, Aakash N, Schaefer K, Rios A, Kanaan Z, Chen L.
    Int J Lab Hematol; 2021 Apr; 43(2):218-226. PubMed ID: 33099879
    [Abstract] [Full Text] [Related]

  • 2. Acute promyelocytic leukemia: Immunophenotype and differential diagnosis by flow cytometry.
    Fang H, Wang SA, Hu S, Konoplev SN, Mo H, Liu W, Zuo Z, Xu J, Jorgensen JL, Yin CC, El Hussein S, Jelloul FZ, Tang Z, Medeiros LJ, Wang W.
    Cytometry B Clin Cytom; 2022 Jul; 102(4):283-291. PubMed ID: 35716019
    [Abstract] [Full Text] [Related]

  • 3. Immunophenotype distinction between acute promyelocytic leukaemia and CD15- CD34- HLA-DR- acute myeloid leukaemia with nucleophosmin mutations.
    Ferrari A, Bussaglia E, Úbeda J, Facchini L, Aventin A, Sierra J, Nomdedéu JF.
    Hematol Oncol; 2012 Sep; 30(3):109-14. PubMed ID: 21812014
    [Abstract] [Full Text] [Related]

  • 4. CD34 negative HLA-DR negative acute myeloid leukaemia: A higher association with NPM1 and FLT3-ITD mutations.
    Gajendra S, Gupta R, Thakral D, Gupta SK, Jain G, Bakhshi S, Sharma A, Sahoo RK, Kumar L, Rai S, Singh S, Upadhyay AD.
    Int J Lab Hematol; 2023 Apr; 45(2):221-228. PubMed ID: 36504282
    [Abstract] [Full Text] [Related]

  • 5. [FLT3-ITD and NPM1 mutation positive acute myeloid leukemia with cuplike blasts mimicking acute promyelocytic leukemia].
    Aoyama K, Yamasaki Y, Mouri F, Maehiro Y, Takaki Y, Oya S, Nakamura T, Morishige S, Yamaguchi M, Nagafuji K.
    Rinsho Ketsueki; 2022 Apr; 63(7):764-769. PubMed ID: 35922945
    [Abstract] [Full Text] [Related]

  • 6. Radar plots facilitate differential diagnosis of acute promyelocytic leukemia and NPM1+ acute myeloid leukemia by flow cytometry.
    Gupta M, Jafari K, Rajab A, Wei C, Mazur J, Tierens A, Hyjek E, Musani R, Porwit A.
    Cytometry B Clin Cytom; 2021 Jul; 100(4):409-420. PubMed ID: 33301193
    [Abstract] [Full Text] [Related]

  • 7. A distinct immunophenotype identifies a subset of NPM1-mutated AML with TET2 or IDH1/2 mutations and improved outcome.
    Mason EF, Kuo FC, Hasserjian RP, Seegmiller AC, Pozdnyakova O.
    Am J Hematol; 2018 Aug; 93(4):504-510. PubMed ID: 29274134
    [Abstract] [Full Text] [Related]

  • 8. Leukemias resembling acute promyelocytic leukemia, microgranular variant.
    Nagendra S, Meyerson H, Skallerud G, Rosenthal N.
    Am J Clin Pathol; 2002 Apr; 117(4):651-7. PubMed ID: 11939742
    [Abstract] [Full Text] [Related]

  • 9. [Association of Next Generation Sequencing Based Genotypic Profiling with MICM Characteristics in NPM1 Mutated Acute Myeloid Leukemia].
    Wang B, Ling Y, Dai L, Gu WY, Zhang XW, Xing SS, Li HQ.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Feb; 30(1):56-60. PubMed ID: 35123604
    [Abstract] [Full Text] [Related]

  • 10. Microgranular and t(11;17)/PLZF-RARalpha variants of acute promyelocytic leukemia also present the flow cytometric pattern of CD13, CD34, and CD15 expression characteristic of PML-RARalpha gene rearrangement.
    Rizzatti EG, Portieres FL, Martins SL, Rego EM, Zago MA, Falcão RP.
    Am J Hematol; 2004 May; 76(1):44-51. PubMed ID: 15114596
    [Abstract] [Full Text] [Related]

  • 11. IDH1 and IDH2 mutations are frequent genetic alterations in acute myeloid leukemia and confer adverse prognosis in cytogenetically normal acute myeloid leukemia with NPM1 mutation without FLT3 internal tandem duplication.
    Paschka P, Schlenk RF, Gaidzik VI, Habdank M, Krönke J, Bullinger L, Späth D, Kayser S, Zucknick M, Götze K, Horst HA, Germing U, Döhner H, Döhner K.
    J Clin Oncol; 2010 Aug 01; 28(22):3636-43. PubMed ID: 20567020
    [Abstract] [Full Text] [Related]

  • 12. Blast phenotype and comutations in acute myeloid leukemia with mutated NPM1 influence disease biology and outcome.
    Mason EF, Hasserjian RP, Aggarwal N, Seegmiller AC, Pozdnyakova O.
    Blood Adv; 2019 Nov 12; 3(21):3322-3332. PubMed ID: 31698462
    [Abstract] [Full Text] [Related]

  • 13. HLA-DRneg patients without acute promyelocytic leukemia show distinct immunophenotypic, genetic, molecular, and cytomorphologic characteristics compared to acute promyelocytic leukemia.
    Oelschlaegel U, Mohr B, Schaich M, Schäkel U, Kroschinsky F, Illmer T, Ehninger G, Thiede C.
    Cytometry B Clin Cytom; 2009 Sep 12; 76(5):321-7. PubMed ID: 19291801
    [Abstract] [Full Text] [Related]

  • 14. [The immunophenotypic and clinical characteristics of NPM1 mutated acute myeloid leukemia patients].
    Liu YR, Chang Y, Ruan GR, Qin YZ, Lai YY, Shi HX, Wang YZ, Li LD, Jiang B, Li JL.
    Zhonghua Xue Ye Xue Za Zhi; 2013 Feb 12; 34(2):98-103. PubMed ID: 23611213
    [Abstract] [Full Text] [Related]

  • 15. How I diagnose and treat NPM1-mutated AML.
    Falini B, Brunetti L, Martelli MP.
    Blood; 2021 Feb 04; 137(5):589-599. PubMed ID: 33171486
    [Abstract] [Full Text] [Related]

  • 16. A Leukemia-Associated CD34/CD123/CD25/CD99+ Immunophenotype Identifies FLT3-Mutated Clones in Acute Myeloid Leukemia.
    Angelini DF, Ottone T, Guerrera G, Lavorgna S, Cittadini M, Buccisano F, De Bardi M, Gargano F, Maurillo L, Divona M, Noguera NI, Consalvo MI, Borsellino G, Bernardi G, Amadori S, Venditti A, Battistini L, Lo-Coco F.
    Clin Cancer Res; 2015 Sep 01; 21(17):3977-85. PubMed ID: 25957287
    [Abstract] [Full Text] [Related]

  • 17. FLT3 and NPM1 mutations in a cohort of AML patients and detection of a novel mutation in tyrosine kinase domain of FLT3 gene from Western India.
    Ghosh K, Swaminathan S, Madkaikar M, Gupta M, Kerketta L, Vundinti B.
    Ann Hematol; 2012 Nov 01; 91(11):1703-12. PubMed ID: 22733614
    [Abstract] [Full Text] [Related]

  • 18. Prognostic factors in acute promyelocytic leukemia: strategies to define high-risk patients.
    Testa U, Lo-Coco F.
    Ann Hematol; 2016 Apr 01; 95(5):673-80. PubMed ID: 26920716
    [Abstract] [Full Text] [Related]

  • 19. [Immunophenotypic features of acute myeloid leukemia with AML-1/ETO fusion gene].
    Zhang JJ, DU X, Huang ZX, Su JH, Zhou MH.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Apr 01; 15(2):378-81. PubMed ID: 17493351
    [Abstract] [Full Text] [Related]

  • 20. Report of a new six-panel flow cytometry marker for early differential diagnosis of APL from HLA-DR negative Non-APL leukemia.
    Mosleh M, Mehrpouri M, Ghaffari S, Saei Z, Agaeipoor M, Jadali F, Satlsar ES, Gholampour R.
    Scand J Clin Lab Invest; 2020 Apr 01; 80(2):87-92. PubMed ID: 31829759
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.